myTomorrows

myTomorrows is an international platform that links patients facing unmet medical needs to treatments in development worldwide.

We bridge the gap between patients who are searching for treatment options and the pharmaceutical companies who provide them At myTomorrows, we believe everyone should be able to access the treatment options which are open to them. We strive to make it easier for physicians and their patients with unmet medical needs to find, get information about, and access pre-approval medicines whenever possible. We believe that by making the process of accessing pre-approval medicines more transparent, we’ll be able to transform the lives of people all over the world. To contact us, please visit https://www.mytomorrows.com/en/get-in-contact.

10/10/2025

AI is moving at record speed - and this week, it was on full display at OpenAI DevDay 2025 in San Francisco! 🚀

Our AI Product Manager and developer, Danny den Hamer, attended alongside other developers, thought leaders and OpenAI employees all eager to build the future using AI. The atmosphere was buzzing with innovation, and one thing was clear: in just a few years, AI has evolved from simple word prediction tools to sophisticated agents capable of handling complex tasks throughout diverse industries.

👉 Danny summed it up perfectly: “Intelligence is no longer the limiting factor for AI adoption across sectors.” Yet, when it comes to healthcare, intelligence must go hand-in-hand with compliance, security, privacy, trust, and transparency.

That’s why at myTomorrows, we’ve built these foundations into our AI-powered platform and new Matching API. With ISO-27001 certification and GDPR, HIPAA, and SOC 2 compliance, healthcare professionals can securely:

✔️ Search and pre-screen patients for clinical trials using AI
✔️ Refer to, and collaborate with sites efficiently
✔️ Access clear, structured information on Expanded Access Programs when clinical trials are not available for a specific patient case
✔️ Manage and track patient information with confidence

💡 Today, our AI-powered platform is already proving the impact:
✔️Up to 98% accuracy in eligibility pre-screening
✔️90% less workload for HCPs looking for clinical trial options for their patients
✔️ Matched 15,000+ patients to clinical trials and Expanded Access Programs (EAPs) across 128 countries to date

✨ Events like DevDay serve as a powerful reminder of why we innovate: not only to push technology forward, but also to ensure it benefits doctors, researchers and patients who need it the most.

🔬At myTomorrows, we’re continuously looking at opportunities for deploying AI. Our engineering team has widely adopted AI coding tools to improve our product even faster, and we will be launching more AI-supported features soon.

10/10/2025

🌍 Today is World Mental Health Day.

This year, we are reflecting on the mental health of people living with serious conditions.

For many, the emotional weight of a diagnosis can be just as heavy as the medical one. Between doctor’s visits, test results, and everyday responsibilities, it’s easy to feel overwhelmed. This is especially true when the standard course of treatments have been exhausted.

That’s why our Patient Navigators place listening and understanding at the heart of every conversation. In a 15–30-minute call in your preferred language, our team takes the time to understand your situation and needs. Every conversation is:

✅ Compassionate and confidential
✅ Flexible to your schedule and needs
✅ Focused on helping you feel supported, not pressured

We are here to support you every step of your clinical research journey, including helping you discover and access clinical trials that may be suitable for you.

On World Mental Health Day, we want to remind everyone: you don’t have to face your journey alone. 💙

09/10/2025

Celebrating women making a difference in HealthTech 👏

Our Chief Operating Officer, Vanessa Lemarié, has been named in Sifted's 100 Women in Tech in Europe 2025 - a recognition that celebrates the most impactful and inspiring women shaping the European technology ecosystem.

At myTomorrows, Vanessa drives operational excellence across clinical trial patient recruitment, expanded access programs, and real-world data. She combines strategic efficiency with a commitment to quality and compliance, whilst reinforcing patient-centricity as a core value.

This approach directly supports our mission to broaden global access to pre-approval treatments via clinical trials and expanded access programs.

💬 In her own words:
“Working in HealthTech truly means working at an intersection of care and technological advancement. At myTomorrows I'm particularly proud of our team who expertly support patients at every step of their journey with safety, compliance and efficiency top of mind.”

👏 Congratulations Vanessa on this well-deserved honor.

🔗 Meet the 100 Women in Tech in Europe 2025: https://eu1.hubs.ly/H0nHTmN0

08/10/2025

⏳ Live from London! Our team is at the Operationalise: Expanded Access Programmes Summit Europe 2025 this week!

Expanded Access programmes (EAPs) play a critical role in enabling treatment options for patients with serious conditions who cannot access investigational medicines through clinical trials. With growing demand across rare diseases, oncology, and advanced therapies, BioPharma organizations face increasing expectations to deliver programmes that are compliant, efficient, and patient-focused.

We’re proud to contribute to the conversation through two key sessions:

📌 October 8, 3:00–3:30 pm BST - Fireside Chat “Why an Expanded Access Management Platform Makes a Difference”, with Dennis Akkaya, Karlijn Doorn and Stephanie Ferket . They will discuss how purpose-built platforms can transform the way EAPs are designed and executed, including:

✔️Simplifying submissions and enabling real-time patient tracking for physicians
✔️Reducing manual effort and ensuring compliance through automated workflows
✔️Enhancing data visibility and stakeholder alignment for operational efficiency

📌 October 9, 1:45-2:15 pm BST – Presentation ‘Real-World Data in Expanded Access: An Integral Part of Evidence Generation’, with Jasmin Schelhaas, on October 9. She will share how real-world data generated from EAPs can be intentionally designed and applied to strengthen evidence strategies, including:

✔️Translating RWD from EAPs into actionable insights
✔️Embedding RWD into evidence strategies to support clinical development and post-approval commitments
✔️Ensuring data meets regulatory and payer requirements through proactive design and rigorous quality standards

We look forward to connecting with peers across Access, Clinical Operations, Medical Affairs, Regulatory, and Supply Chain to share insights and learn from your experiences.

👉 Let’s meet! Book a 1:1 with our team here: https://eu1.hubs.ly/H0nFbDh0

06/10/2025

We’re gearing up for the Operationalise: Expanded Access Programmes Summit Europe 2025, taking place this week in London. 🚀

Over the course of three days, 120+ senior leaders across Access, Clinical Operations, Medical Affairs, Regulatory, and Supply Chain will come together to exchange best practices on designing and executing Expanded Access Programmes (EAPs). Our team is proud to play an active role in shaping the discussions.

🔍 Gain insights from our experts on how to optimize your EAPs:

✔️Dennis Akkaya (Chief Commercial Officer), Karlijn Doorn, PhD (Head of Partnerships & Customer Success), and Stephanie Ferket (Director, Expanded Access Strategy & Customer Success) will host a fireside chat on “Why an Expanded Access Management Platform Makes a Difference” on October 8, 3:00–3:30 pm BST.

✔️Jasmin Schelhaas (Real-World Data Specialist) will give a presentation on “Real-World Data in Expanded Access: An Integral Part of Evidence Generation” on October 9, 1:45-2:15 pm BST

These sessions will cover how digital solutions and real-world data can improve physician engagement, streamline operations, and generate evidence that supports regulatory and payer decision-making.

💚Beyond the stage, our full Mighty team, including Nicola Laschi (Director, Pharma Partnerships) and Elena Merino Rodriguez, PhD (Senior Program Manager, Expanded Access Programmes), will also be on site and available for conversations about compliance, operational efficiency, digital platforms, and evidence generation in EAPs.

We look forward to connecting with you in London and exploring opportunities to strengthen your EAP strategy.

👉 Secure a 1:1 with our team here: https://eu1.hubs.ly/H0nyMVc0

06/10/2025

🚀 We’re hiring: Senior DevOps Engineer
🔗https://eu1.hubs.ly/H0nyHLG0

Join our growing team! Become a part of our dynamic group of Mighties with diverse backgrounds in Medical, Pharma, Tech, and Business. This is an exciting opportunity to join our ambitious company as it grows.

With benefits like flexible working, a learning and development budget, and an annual performance bonus, you’ll be based in Amsterdam with a fast-growing company of 80+ people, with 30 nationalities, helping patients to know all their treatment options. 💚

👉Our full list: https://eu1.hubs.ly/H0nyLgX0

02/10/2025

We're excited to share that myTomorrows has been nominated for the Deloitte Technology Fast 50 Award! 🎉

This is a fantastic recognition of our team's hard work and dedication to innovation.

We’re eagerly looking forward to the Technology Fast 50 award show on November 6th, where we’ll discover the final Fast 50 ranking. 🚀

A big thank you to everyone who has supported us so far on this journey.

👉 Find out more about the Netherlands Fast 50 here: https://eu1.hubs.ly/H0nvxKk0

📢 Stay tuned for the results!
and

01/10/2025

🌍 myTomorrows is attending SCOPE Europe 2025 in Barcelona!

Patient recruitment remains one of the toughest challenges in clinical research. And at its core, SCOPE Europe is about driving innovation and collaboration to improve clinical trial planning, operations, and ex*****on.

At myTomorrows, we’re excited to contribute to that conversation by sharing how our solutions help biopharma companies accelerate trial enrollment, while enabling CROs and sites to connect with patients faster and more effectively

🎤 Don’t miss our presentation “ Patient recruitment – A multi-stakeholder approach for EU program success”, with Danny den Hamer and Christa Reefman

📅 Tuesday, October 14 | ⏰ 10:40 AM

We’ll discuss how platform models streamline recruitment, the role of Patient Navigators in expanding trial access, and how biopharma can enhance CRO workflow.

Interested in continuing the conversation? Our full Mighty team, including also Karlijn Doorn, PhD, Head of Partnerships & Customer Success and Theo Cantero, Patient Navigator, will be at booth #13. Visit us to explore how we can help you:

✔️Accelerate patient recruitment and enrollment
✔️Strengthen collaboration with CROs and clinical sites
✔️Support cross-border referrals and improve trial access through Patient Navigators

👉 Or book a meeting with us: https://eu1.hubs.ly/H0ntk000

30/09/2025

Awareness is most powerful when it inspires action.💪

On Limb-Girdle Muscular Dystrophy (LGMD) Awareness Day, we stand alongside the individuals and families living with this condition. LGMD causes muscle weakness and wasting, and over time, activities such as walking, climbing stairs, or managing everyday tasks can become more challenging.

Our efforts focus on three pillars:

🤝 Collaboration
We work with partners such as the Curelgmd2i Foundation. By raising awareness, advocating for patients, and advancing research into LGMD2I/R9, they bring strength to the community. Together, we can amplify patient voices and support efforts toward better care.

📚 Knowledge
Sharing clear, educational resources helps people and their families to feel informed and empowered. That’s why we recently updated two blogs to answer common questions from the LGMD community:

➤ What does LGMD mean for everyday life and how might it progress? https://eu1.hubs.ly/H0nrq0j0
➤ Which tools, therapies, and resources can support mobility and independence? https://eu1.hubs.ly/H0nrqjS0

💡 Guidance
At myTomorrows, we provide information and support for people navigating rare diseases during their clinical research discovery journey. As part of this process, our multilingual patient navigator team helps people to discover and potentially connect with clinical trials. Operating globally, the team ensures every family, regardless of location, receives empathetic and personalized assistance.

Through collaboration, knowledge, and guidance, we aim to build a future where people with LGMD feel seen, supported, and empowered.💚

29/09/2025

Real progress in ALS research happens when every voice comes together - sites, BioPharma, advocacy groups, and patients. NEALS 2025 is where that collaboration takes shape, and we're looking forward to being part of it.

📅 7-10 October 2025
📍 Clearwater, FL

At NEALS, we want to hear directly from you. Whether you are a clinical researcher, a BioPharma partner, or part of a patient advocacy group, your experiences and ideas are valuable to us. Together, we can uncover new approaches that make ALS trials more accessible and sustainable.

At our booth, you'll have the opportunity to:
✔️Explore practical strategies to strengthen trial recruitment and enrollment.
✔️Learn how we're partnering with advocacy groups to ensure the patient voice shapes trial design and access strategies.
✔️Identify collaboration opportunities that unite sites, BioPharma, and PAGs to drive long-term sustainability in ALS research.

📌 We'll also be presenting our poster: "From Awareness to Enrollment: Navigating Patient Challenges to Improve Access to ALS Clinical Trials" on October 9, 4:20-6:20 pm. Come by to share your perspective, continue the conversation, and explore ways we can move ALS research forward together.

👉 Book a 1:1 meeting with our team here: https://eu1.hubs.ly/H0npQFB0

👥 Our team at NEALS 2025:
🔹Dennis Akkaya - Chief Commercial Officer
🔹Adrianne Rivard - Senior Community Development Manager
🔹Paris Asif, PhD - Program Manager, Clinical Trial Operations

We're excited to connect with sites, BioPharma partners, and advocacy groups to spark new ideas and strengthen the ALS research ecosystem.

25/09/2025

September is Duchenne Awareness Month ☀️

Earlier this month, on International Duchenne Awareness Day, our global myTomorrows teams wore red to raise awareness and reaffirm our commitment to the Duchenne community worldwide.

💚 We continue to spread awareness. This time, our colleagues from New York City, New Jersey and Kochi have joined in, lending their voices to this important cause. Together, across continents and time zones, we remain united in our support.

💡While September shines a spotlight on Duchenne, our mission at myTomorrows goes far a single month. Every day, our patient navigators work alongside families, providing clear, empathetic guidance through the clinical research journey, ensuring they always feel informed, supported, and never alone.

Whilst this awareness month may last 30 days, our support for the Duchenne community is all year round. 💪

24/09/2025

⏰ Mark your calendars! The Operationalise: Expanded Access Programmes Summit Europe 2025 is around the corner, and our team will be there!

📍 London | 7–9 October

Hosted by Hanson Wade, this summit is the leading European meeting for BioPharma professionals designing and executing early access programmes (EAPs). With growing demand across rare diseases, oncology, and advanced therapies, the need to deliver effective, compliant, and patient-centered expanded access solutions has never been greater.

🎤 Our team will be actively contributing to this conversation across fireside chats, presentations, and discussions. Here’s where to find us on stage:

👉 On October 8, Dennis Akkaya (Chief Commercial Officer), Karlijn Doorn, PhD (Head of Partnerships & Customer Success), and Stephanie Ferket (Director, Expanded Access Strategy & Customer Success) will host a fireside chat on “Why an Expanded Access Management Platform Makes a Difference”.

👉 On October 9, Jasmin Schelhaas (Real-World Data Specialist) will deliver a presentation on “Real-World Data in Expanded Access: An Integral Part of Evidence Generation”.

And of course, our full Mighty team, including Nicola Laschi (Director, Pharma Partnerships) and Elena Merino Rodriguez, PhD (Senior Program Manager, Expanded Access Programmes), will also be there to connect and discuss how to strengthen your EAP strategy. 💚

💡 Look for us to discuss how to:
✔️ Streamline the operational complexity of EAPs across regions
✔️Use digital platforms to ease manual burden and support audit readiness
✔️ Explore collaboration opportunities to strengthen your EAP strategy

Let’s talk about your EAP strategy!

Adres

Anthony Fokkerweg 61
Amsterdam
1059CP

Website

https://myTomorrows.com/

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer myTomorrows nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.